Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway (vol 41, pg 2689, 2019)

被引：0
|
作者：
Sun, Wei
Li, Luo
Du, Zhongbo
Quan, Zhen
Yuan, Mengjuan
Cheng, Honglin
Gao, Yingying
Luo, Chunli
Wu, Xiaohou
机构：
来源：
ONCOLOGY REPORTS | 2022年 / 48卷 / 06期
关键词：
D O I：
10.3892/or.2022.8426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 13 条
  • [1] Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
    Sun, Wei
    Li, Luo
    Du, Zhongbo
    Quan, Zhen
    Yuan, Mengjuan
    Cheng, Honglin
    Gao, Yingying
    Luo, Chunli
    Wu, Xiaohou
    ONCOLOGY REPORTS, 2019, 41 (05) : 2689 - 2702
  • [2] Down-Regulation of the Androgen Receptor by G-Quadruplex Ligands Sensitizes Castration-Resistant Prostate Cancer Cells to Enzalutamide
    Tassinari, Martina
    Cimino-Reale, Graziella
    Nadai, Matteo
    Doria, Filippo
    Butovskaya, Elena
    Recagni, Marta
    Freccero, Mauro
    Zaffaroni, Nadia
    Richter, Sara N.
    Folini, Marco
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8625 - 8638
  • [3] Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/androgen receptor signaling pathway
    Chen, Xiong
    Yang, Guo
    Liu, Miao
    Quan, Zhen
    Wang, Leilei
    Luo, Chunli
    Wu, Xiaohou
    Zheng, Yongbo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 613 : 53 - 60
  • [4] PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration-resistant prostate cancer by suppressing the wnt3a/-catenin pathway
    Li, Luo
    Du, Zhongbo
    Gao, Yingying
    Tang, Yu
    Fan, Yanru
    Sun, Wei
    Li, Ting
    Liu, Nanjing
    Yuan, Mengjuan
    Fan, Jiaxin
    Niu, Lingfang
    Yan, Jinxiao
    Duan, Limei
    Wu, Xiaohou
    Luo, Chunli
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 15472 - 15486
  • [5] Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (vol 20, pg 3198, 2014)
    Liu, C.
    Lou, W.
    Zhu, Y.
    Nadiminty, N.
    Schwartz, C. T.
    Evans, C. P.
    CLINICAL CANCER RESEARCH, 2017, 23 (01) : 323 - 323
  • [6] Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer (vol 116, pg 631, 2018)
    Zadra, Giorgia
    Ribeiro, Caroline F.
    Chetta, Paolo
    Cacciatore, Stefano
    Gao, Xueliang
    Syamala, Sudeepa
    Bango, Clyde
    Photopoulos, Cornelia
    Huang, Ying
    Tyekucheva, Svitlana
    Bastos, Debora C.
    Tchaicha, Jeremy
    Lawney, Brian
    Uo, Takuma
    D'Anello, Laura
    Csibi, Alfredo
    Kalekar, Radha
    Larimer, Benjamin
    Ellis, Leigh
    Butler, Lisa M.
    Morrissey, Colm
    McGovern, Karen
    Palombella, Vito J.
    Kutok, Jeffery L.
    Mahmood, Umar
    Bosari, Silvano
    Adams, Julian
    Peluso, Stephane
    Dehm, Scott M.
    Plymate, Stephen R.
    Loda, Massimo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (31) : 18893 - 18893
  • [7] Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer
    Grimm, Marc-Oliver
    Foller, Susan
    Leucht, Katharina
    UROLOGIE, 2023, : 1269 - 1280
  • [8] DHX15 is upregulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations (vol 79, pg 657, 2019)
    Xu, Yadong
    Song, Qiong
    Pascal, Laura E.
    Zhong, Mingming
    Zhou, Yibin
    Zhou, Jianhua
    Deng, Fang-Ming
    Huang, Jiaoti
    Wang, Zhou
    PROSTATE, 2019, 79 (15): : 1789 - 1789
  • [9] The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program (vol 13, pg 1121, 2019)
    Parolia
    MOLECULAR ONCOLOGY, 2020, 14 (02) : 484 - 484
  • [10] Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration- Resistant Prostate Cancer (vol 5, pg 1060, 2019)
    De Laere, B.
    Rajan, P.
    Gronberg, H.
    Dirix, L.
    Lindberg, J.
    JAMA ONCOLOGY, 2019, 5 (07) : 1070 - 1070
12